Satara: According to some state officials, India’s Covid 19 vaccination campaign also suffered some delays on Sunday due to errors in an app used for campaign coordination.
Prime Minister Narendra Modi on Saturday launched what his government has described as “the world’s largest vaccination program”. It aims to vaccinate about 300 million people in India to prevent the spread of the disease, the second largest coronavirus case after the United States.
More than 300,000 people in India were to be vaccinated against polio on Saturday, but only 191,181 were vaccinated on the first day, according to official figures.
Officials in at least four states said many health workers who had to be vaccinated on Saturday did not receive a message from the government through an app called One One. At least one state official said problems remained unresolved on Sunday.
The health partner is supposed to inform health workers, who are the first to take shots. It also allows personnel to oversee and manage the entire program.
“We were planning to vaccinate 28,500 people on Saturday but could only do 18,328 due to a glitch in the One app,” said a senior health official from the western state of Maharashtra.
The state of India has been most affected by Maharashtra Cove 19, located in Mumbai’s financial hub.
In the eastern states of Odisha and West Bengal, officials said problems with the app forced them to use printout on Saturday.
In Bhubaneswar, the state capital, “We also went with our Plan B and reached out to people to get vaccinated directly offline.”
The Indian government did not respond to a request for comment on Sunday.
“The efficiency and speed of the system has been improved and is being further improved,” Manohar Agnani, a senior health ministry official, said on Saturday.
The eastern state of West Bengal was also in trouble on Sunday.
“The issue has not been resolved yet and we are facing serious hurdles,” said Dr Ajoy Chakraborty, director of health services in West Bengal.
Officials in other states could not be reached for comment Sunday.
India is currently using the Oxford University / AstraZeneca vaccine in the UK, which is also being developed in India, and the government-backed vaccine is being developed by India Biotech.
However, health experts and opposition lawmakers have criticized the approval of Bharat Biotech’s Covacan, which the manufacturer is still pursuing, due to a lack of utility data.